Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 10601-10650 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT06755658
RDW, Platelet Kinetics and Survival Outcome in Covid-19 Hospitalized Patients.
N/AActive, not recruiting
500 participants
Started: Nov 1, 2021 · Completed: May 30, 2025
1 condition1 sponsor1 location
NCT04618406
The Effect of Negative Pressure Wound Therapy on Wound Healing in Major Amputations of the Lower Limb
NAActive, not recruiting
160 participants
Started: Nov 1, 2021 · Completed: Jul 31, 2025
3 conditions1 sponsor1 location
NCT04971356
1-month DAPT Plus 5-month Ticagrelor Monotherapy Versus 12-month DAPT in Patients With Drug-coated Balloon
NAActive, not recruiting
1,948 participants
Started: Nov 1, 2021 · Completed: Dec 1, 2026
3 conditions1 sponsor1 location
NCT05049174
Nurse-led Smoking Cessation Program With Follow-up in Healthy Life Centres: a Randomized Clinical Trial
NAActive, not recruiting
221 participants
Started: Nov 1, 2021 · Completed: Apr 30, 2024
4 conditions5 sponsors3 locations
NCT05033119
PROSA: Prolactin, Sex Hormones, Growth and Metabolic Biomarkers in Children and Adolescents on Antipsychotics
N/AActive, not recruiting
90 participants
Started: Nov 1, 2021 · Completed: Oct 31, 2024
5 conditions4 sponsors3 locations
NCT05099978
Asian Multicenter Prospective Study of ctDNA Sequencing
N/AActive, not recruiting
506 participants
Started: Nov 1, 2021 · Completed: Dec 31, 2024
6 conditions1 sponsor19 locations
NCT05416216
Wellbeing of the ECE Workforce in Low-resourced Locations
NAActive, not recruiting
360 participants
Started: Nov 1, 2021 · Completed: Sep 30, 2026
3 conditions1 sponsor5 locations
NCT06434545
Symptom Management Essentials at Home
NAActive, not recruiting
800 participants
Started: Nov 1, 2021 · Completed: Jul 1, 2026
1 condition5 sponsors1 location
NCT05520203
Role Development, Implementation and Evaluation of Nurse Practitioners
N/AActive, not recruiting
1,000 participants
Started: Nov 1, 2021 · Completed: Dec 1, 2024
3 conditions2 sponsors2 locations
NCT05027477
A Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate Cancer
NAActive, not recruiting
201 participants
Started: Nov 1, 2021 · Completed: Aug 31, 2036
2 conditions1 sponsor22 locations
NCT06279936
Neurobiological Underpinnings of Neuropsychological Consequences in Long COVID
N/AActive, not recruiting
130 participants
Started: Nov 1, 2021 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT05256771
Electrical Muscle Stimulation with 1064 Nm Diode Laser and RF/PEMF for Non-invasive Body Contouring and Fat Reduction.
NAActive, not recruiting
36 participants
Started: Nov 1, 2021 · Completed: Sep 30, 2025
2 conditions1 sponsor3 locations
NCT05144321
Twin Pregnancy Cohort
N/AActive, not recruiting
150 participants
Started: Nov 1, 2021 · Completed: Dec 1, 2026
2 conditions1 sponsor1 location
NCT05037149
Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors
PHASE1Active, not recruiting
50 participants
Started: Nov 1, 2021 · Completed: Mar 30, 2024
1 condition1 sponsor9 locations
NCT04788836
How Altered Gut-Brain-Axis Influences Food Choices: Part 2 (BrainFood)
N/AActive, not recruiting
61 participants
Started: Nov 1, 2021 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT05142709
Real-world Experience of ICIs Plus Chemotherapy for Advanced ESCC.
N/AActive, not recruiting
600 participants
Started: Oct 31, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor23 locations
NCT05026827
Iyengar Yoga for Prolonged Grief Disorder
NAActive, not recruiting
68 participants
Started: Oct 31, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04326478
Single Dose Azithromycin to Prevent Cholera in Children
PHASE2Active, not recruiting
920 participants
Started: Oct 31, 2021 · Completed: May 31, 2026
1 condition2 sponsors1 location
NCT04897776
Stimulation of the Thalamus for Arousal Restoral in Temporal Lobe Epilepsy
NAActive, not recruiting
5 participants
Started: Oct 31, 2021 · Completed: Aug 31, 2025
1 condition4 sponsors3 locations
NCT04454073
Investigation of Factors Associated With Preserved Cognitive Function in Bipolar Disorder
N/AActive, not recruiting
87 participants
Started: Oct 29, 2021 · Completed: Dec 1, 2026
1 condition1 sponsor1 location
NCT05014204
Safety and Feasibility of Novel Therapy for Duodenal Mucosal Regeneration for Type II Diabetes
NAActive, not recruiting
20 participants
Started: Oct 29, 2021 · Completed: Mar 31, 2025
7 conditions1 sponsor3 locations
NCT04899141
Prospective Registry of ihtDEStiny® Coronary Stent in Regular PCI Practice
N/AActive, not recruiting
400 participants
Started: Oct 29, 2021 · Completed: Apr 1, 2025
2 conditions1 sponsor20 locations
NCT05085548
ProAgio in Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies
PHASE1Active, not recruiting
58 participants
Started: Oct 29, 2021 · Completed: Nov 30, 2025
2 conditions2 sponsors1 location
NCT05076513
Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma
EARLY_PHASE1Active, not recruiting
42 participants
Started: Oct 29, 2021 · Completed: Sep 30, 2025
6 conditions5 sponsors1 location
NCT05050955
AlloSure Lung Assessment and Metagenomics Outcomes Study
N/AActive, not recruiting
550 participants
Started: Oct 29, 2021 · Completed: Dec 31, 2028
3 conditions1 sponsor22 locations
NCT05172024
Understanding the Long-term Impact of COVID-19 in Adults (RECOVER)
N/AActive, not recruiting
15,172 participants
Started: Oct 29, 2021 · Completed: May 23, 2026
1 condition2 sponsors86 locations
NCT04954339
DYNAmic Immune Microenvironment of HCC Treated With atezolIzumab Plus bevaCizumab
PHASE2Active, not recruiting
40 participants
Started: Oct 29, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05140369
CLL Therapy Approaches in Russia
N/AActive, not recruiting
6,000 participants
Started: Oct 29, 2021 · Completed: Dec 31, 2027
1 condition1 sponsor34 locations
NCT05469438
IMAS Optimization and Applicability in an Acute Stroke Setting.
N/AActive, not recruiting
30 participants
Started: Oct 29, 2021 · Completed: Sep 30, 2025
1 condition2 sponsors2 locations
NCT05070156
B010-A Injection for Treating Patients With GPC3 Positive Advanced Hepatocellular Carcinoma
EARLY_PHASE1Active, not recruiting
3 participants
Started: Oct 29, 2021 · Completed: Sep 30, 2024
1 condition2 sponsors1 location
NCT04943341
Evaluation of the Triamcinolone -Acetonide Therapy for the Treatment of the Medial Plica Syndrome
NAActive, not recruiting
30 participants
Started: Oct 28, 2021 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05021536
Phase III Trial of AMX0035 for Amyotrophic Lateral Sclerosis Treatment
PHASE3Active, not recruiting
664 participants
Started: Oct 28, 2021 · Completed: Jan 1, 2026
1 condition1 sponsor69 locations
NCT05122988
Facing Adverse Childhood Experiences
N/AActive, not recruiting
2,606 participants
Started: Oct 28, 2021 · Completed: Nov 30, 2024
1 condition1 sponsor1 location
NCT04493645
Ankle Instability Using Foot Intensive Rehabilitation
NAActive, not recruiting
150 participants
Started: Oct 28, 2021 · Completed: Dec 1, 2025
2 conditions4 sponsors1 location
NCT05139225
A Study of TTI-622 in Combination With Daratumumab Hyaluronidase-fihj in People With Multiple Myeloma
PHASE1Active, not recruiting
7 participants
Started: Oct 28, 2021 · Completed: Oct 31, 2025
1 condition2 sponsors7 locations
NCT05068752
Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancer
PHASE2Active, not recruiting
12 participants
Started: Oct 28, 2021 · Completed: Dec 30, 2024
1 condition3 sponsors1 location
NCT05043090
Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC
PHASE3Active, not recruiting
148 participants
Started: Oct 28, 2021 · Completed: Oct 30, 2025
1 condition1 sponsor139 locations
NCT06307301
Study in ALS With Abatacept & IL-2
PHASE1Active, not recruiting
5 participants
Started: Oct 28, 2021 · Completed: Oct 17, 2024
1 condition1 sponsor1 location
NCT04302324
A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to Daratumumab
PHASE2Active, not recruiting
9 participants
Started: Oct 28, 2021 · Completed: Dec 28, 2027
3 conditions2 sponsors1 location
NCT05029635
Phase III Study on HMPL-523 for Treatment of ITP
PHASE3Active, not recruiting
272 participants
Started: Oct 27, 2021 · Completed: May 30, 2025
1 condition1 sponsor37 locations
NCT05096338
Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate Cancer
N/AActive, not recruiting
200 participants
Started: Oct 27, 2021 · Completed: Nov 30, 2029
4 conditions2 sponsors1 location
NCT05117242
Safety and Efficacy Study of GEN1046 as a Single Agent or in Combination With Pembrolizumab for Treatment of Recurrent (Non-small Cell) Lung Cancer
PHASE2Active, not recruiting
125 participants
Started: Oct 27, 2021 · Completed: Mar 31, 2027
1 condition2 sponsors42 locations
NCT05142462
Post Market Clinical Follow-up of EUROSCUP Fixe Acetabular Cup
N/AActive, not recruiting
120 participants
Started: Oct 27, 2021 · Completed: Jul 31, 2032
6 conditions1 sponsor4 locations
NCT05091190
Immunotherapy Clearance and Phenotype of Circulating Tumor Cells in Lung and Head and Neck Cancers
NAActive, not recruiting
75 participants
Started: Oct 27, 2021 · Completed: Dec 11, 2026
2 conditions1 sponsor2 locations
NCT05049993
Pyrocarbon Clinical Follow-up Study
N/AActive, not recruiting
76 participants
Started: Oct 27, 2021 · Completed: Dec 31, 2027
3 conditions1 sponsor8 locations
NCT05181592
Assessment of Effectiveness and Safety of Luspatercept in Patients Suffering From Lower-risk Myelodysplastic Syndrome.
PHASE3Active, not recruiting
70 participants
Started: Oct 27, 2021 · Completed: Feb 28, 2027
1 condition2 sponsors13 locations
NCT05090566
MagnetisMM-4: Umbrella Study of Elranatamab (PF-06863135) in Combination With Anti-Cancer Treatments in Multiple Myeloma
PHASE2Active, not recruiting
34 participants
Started: Oct 27, 2021 · Completed: Feb 19, 2026
1 condition1 sponsor33 locations
NCT04988386
Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants
PHASE3Active, not recruiting
389 participants
Started: Oct 27, 2021 · Completed: May 15, 2028
1 condition1 sponsor72 locations
NCT04712097
A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide With a US Extension of Mosunetuzumab in Combination With Lenalidomide in Participants With Follicular Lymphoma
PHASE3Active, not recruiting
478 participants
Started: Oct 27, 2021 · Completed: Dec 31, 2029
1 condition1 sponsor112 locations
NCT05091021
Skeletal Effects of Chronic Night Shift
N/AActive, not recruiting
40 participants
Started: Oct 27, 2021 · Completed: Feb 28, 2026
2 conditions2 sponsors1 location